Status and phase
Conditions
Treatments
About
This is a study to assess the safety and bioeffect of REGN1033 (SAR391786) in healthy volunteers.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial and not all inclusion/ exclusion criteria are listed.
Primary purpose
Allocation
Interventional model
Masking
125 participants in 4 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal